â‚©
3380.00
Oct 29
Business Description
Gene Bio Tech Co Ltd
ISIN : KR7086060001
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.47 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.32 | |||||
Debt-to-EBITDA | 3.36 | |||||
Interest Coverage | 5.7 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.35 | |||||
Beneish M-Score | -2.69 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.4 | |||||
3-Year EBITDA Growth Rate | 34.7 | |||||
3-Year EPS without NRI Growth Rate | 15.6 | |||||
3-Year Book Growth Rate | 2.4 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 20.51 | |||||
9-Day RSI | 31.37 | |||||
14-Day RSI | 36.41 | |||||
6-1 Month Momentum % | -6.06 | |||||
12-1 Month Momentum % | -11.21 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.93 | |||||
Quick Ratio | 2 | |||||
Cash Ratio | 1.25 | |||||
Days Inventory | 86.32 | |||||
Days Sales Outstanding | 55.79 | |||||
Days Payable | 21.37 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -2.37 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 16.61 | |||||
Operating Margin % | 4.43 | |||||
Net Margin % | 3.03 | |||||
FCF Margin % | 1.93 | |||||
ROE % | 5.02 | |||||
ROA % | 3.58 | |||||
ROIC % | 7.17 | |||||
3-Year ROIIC % | 36.42 | |||||
ROC (Joel Greenblatt) % | 9.62 | |||||
ROCE % | 6.54 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 12.02 | |||||
PE Ratio without NRI | 11.65 | |||||
PS Ratio | 0.37 | |||||
PB Ratio | 0.59 | |||||
Price-to-Tangible-Book | 0.6 | |||||
Price-to-Free-Cash-Flow | 18.89 | |||||
Price-to-Operating-Cash-Flow | 14.11 | |||||
EV-to-EBIT | 6.4 | |||||
EV-to-EBITDA | 4.57 | |||||
EV-to-Revenue | 0.27 | |||||
EV-to-FCF | 14.22 | |||||
Price-to-Projected-FCF | 1.32 | |||||
Price-to-Median-PS-Value | 0.48 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.89 | |||||
Price-to-Graham-Number | 0.56 | |||||
Price-to-Net-Current-Asset-Value | 0.87 | |||||
Price-to-Net-Cash | 12.57 | |||||
Earnings Yield (Greenblatt) % | 15.6 | |||||
FCF Yield % | 5.32 | |||||
Forward Rate of Return (Yacktman) % | 5.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Gene Bio Tech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 80,028.377 | ||
EPS (TTM) (â‚©) | 281 | ||
Beta | 0.67 | ||
Volatility % | 10.56 | ||
14-Day RSI | 36.41 | ||
14-Day ATR (â‚©) | 88.287239 | ||
20-Day SMA (â‚©) | 3491.25 | ||
12-1 Month Momentum % | -11.21 | ||
52-Week Range (â‚©) | 3125 - 4745 | ||
Shares Outstanding (Mil) | 8.61 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Gene Bio Tech Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Gene Bio Tech Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Gene Bio Tech Co Ltd Frequently Asked Questions
What is Gene Bio Tech Co Ltd(XKRX:086060)'s stock price today?
When is next earnings date of Gene Bio Tech Co Ltd(XKRX:086060)?
Does Gene Bio Tech Co Ltd(XKRX:086060) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |